Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
- PMID: 35444211
- PMCID: PMC9021184
- DOI: 10.1038/s41598-022-10918-1
Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
Erratum for
-
Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients.Sci Rep. 2021 Jan 13;11(1):1171. doi: 10.1038/s41598-020-80938-2. Sci Rep. 2021. PMID: 33441921 Free PMC article.
Similar articles
-
Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.Kidney Int. 1982 Jun;21(6):862-7. doi: 10.1038/ki.1982.110. Kidney Int. 1982. PMID: 6897087
-
Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.Perit Dial Int. 1999 Sep-Oct;19(5):455-61. Perit Dial Int. 1999. PMID: 11379859
-
The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.Am J Kidney Dis. 2005 Nov;46(5):925-32. doi: 10.1053/j.ajkd.2005.08.013. Am J Kidney Dis. 2005. PMID: 16253734
-
Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review.Perit Dial Int. 2006 May-Jun;26(3):366-73. Perit Dial Int. 2006. PMID: 16722031 Review.
-
Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review.JBI Database System Rev Implement Rep. 2019 Jan;17(1):49-73. doi: 10.11124/JBISRIR-2017-003740. JBI Database System Rev Implement Rep. 2019. PMID: 30204711
Publication types
LinkOut - more resources
Full Text Sources